
Nanox.AI’s HealthCCSng Reveals Hidden Cardiovascular Risks in Routine CT Scans
Nanox.AI, a subsidiary of NANO-X IMAGING LTD, has unveiled the results of a clinical study conducted in collaboration with Beilinson Hospital, one of Israel’s top medical institutions. The study employed Nanox.AI’s HealthCCSng, an AI-powered tool designed for cardiac health assessment. The study found that 58% of patients who underwent routine CT scans unknowingly had moderate to severe levels of coronary artery calcium (CAC), a strong indicator of potential cardiac events.
Nanox.AI’s HealthCCSng solution is built on deep-learning technology and utilizes data from standard chest CT scans to automatically quantify and analyze CAC category, helping to identify hidden cardiovascular risks. The study, sponsored by Nanox.AI, sheds light on the importance of early risk identification in cardiac care and demonstrates how AI can play a crucial role in this process. Coronary artery calcium is recognized as one of the best predictors of future cardiac events. Patients falling into the highest CAC category are over 20 times more likely to experience a cardiac event. There is a well-established correlation between the presence of coronary artery calcium and the severity of cardiovascular disease.
Professor Ran Kornowski, Director of the Cardiology Center at Beilinson Hospital, highlighted the significance of the study’s findings: “Nanox’s AI technology can enable physicians to route these unsuspecting individuals with high CAC levels to the appropriate care pathways and treatment.”
The clinical study used Nanox.AI’s HealthCCSng software to assess Coronary Artery Calcification (CAC) levels from non-gated, non-contrast chest CT scans. Two radiologists qualitatively reviewed the software’s categorizations, which include low (CAC 0-99), moderate (CAC 100-399), and severe (CAC > 400) categories. Patients with severe CAC levels were referred to specialized preventive cardiology clinics, while those with low and moderate CAC were directed to primary care physicians for further evaluation.
Prof. Ashraf Hamdan, Head of Cardiovascular Imaging at Beilinson Hospital and chief investigator, highlighted the promising outcomes of the study: “Even within our health-conscious population, we were able to identify a significant number of individuals with hidden cardiovascular disease and guide them onto the appropriate care trajectory.”